Sanofi EPS - Earnings per Share 2012-2026 | SNY

Sanofi earnings per share (EPS) for the twelve months ending March 31, 2026 was $3.59, a 32.66% increase year-over-year.

  • Sanofi EPS for the quarter ending March 31, 2026 was $0.78, a 2.12% decline year-over-year.
  • Sanofi 2025 annual EPS was $3.62, a 51.06% increase from 2024.
  • Sanofi 2024 annual EPS was $2.4, a 3.01% increase from 2023.
  • Sanofi 2023 annual EPS was $2.33, a 33.68% decline from 2022.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.

Sanofi EPS - Earnings per Share 2012-2026 | SNY

  • Sanofi EPS for the quarter ending March 31, 2026 was $0.78, a 2.12% decline year-over-year.
  • Sanofi 2025 annual EPS was $3.62, a 51.06% increase from 2024.
  • Sanofi 2024 annual EPS was $2.4, a 3.01% increase from 2023.
  • Sanofi 2023 annual EPS was $2.33, a 33.68% decline from 2022.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B